digital brain illustration

Welcome to Neuropsychopharmacology

An official publication of the American College of Neuropsychopharmacology 


  • November 2023: Integrating public health and translational basic science to address challenges of xylazine adulteration of fentanyl

  • This is a new article type for trainees and early-stage investigators (within 10 years of terminal research degree or residency and have not had R01 or equivalent) to share their scientific ideas and perspectives. If discussing a current debate, we encourage authors to provide the historical context and suggest constructive approaches. Pre-submission inquiries required, click here for details.

  • To improve rigor and transparency in clinical research published in NPP, submitting authors are now required to answer questions that confirm whether their manuscript includes a clinical trial. Submissions involving clinical trials must include a CONSORT checklist, CONSORT flow diagram, and a registry number.

Neuropsychopharmacology is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.


Hands and arms of multiple skin shades facing up and down, touching, in a row.

Highlighting Research on Health Disparities

A collection aimed at highlighting NPP articles and commentaries that address disparities related to gender, race, ethnicity, LGBTQ+ individuals, and early life adversity